Bio-Rad Laboratories, Inc. company mark

Bio-Rad Laboratories, Inc. Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: BIO
Sector: Healthcare
Industry: Medical Devices
Market Cap $8.96B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

Bio-Rad Laboratories, Inc. Business Intelligence Hub

The Bio-Rad Laboratories, Inc. Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on Bio-Rad Laboratories, Inc.. This page always opens the latest Business Intelligence annual report and stays in sync with Bio-Rad Laboratories, Inc.'s newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

Bio-Rad Laboratories, Inc. Financial Performance & Statements

Explore Bio-Rad Laboratories, Inc.'s financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

Bio-Rad Laboratories, Inc. Quarterly Earnings & Management Commentary

Read the latest Bio-Rad Laboratories, Inc. quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

Bio-Rad Laboratories, Inc. Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

Bio-Rad Laboratories, Inc. Sector, Valuation & Risk Analysis

See Bio-Rad Laboratories, Inc. in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: Bio-Rad Laboratories, Inc. annual report, Bio-Rad Laboratories, Inc. AI annual report, Bio-Rad Laboratories, Inc. fundamental analysis, Bio-Rad Laboratories, Inc. business analysis, Bio-Rad Laboratories, Inc. financial performance, Bio-Rad Laboratories, Inc. financial statements, Bio-Rad Laboratories, Inc. growth analysis, Bio-Rad Laboratories, Inc. management analysis, Bio-Rad Laboratories, Inc. corporate governance, Bio-Rad Laboratories, Inc. cash flow analysis, Bio-Rad Laboratories, Inc. business intelligence, Bio-Rad Laboratories, Inc. valuation, Bio-Rad Laboratories, Inc. quarterly results, Bio-Rad Laboratories, Inc. earnings summary, Bio-Rad Laboratories, Inc. management commentary, Bio-Rad Laboratories, Inc. sector analysis, Bio-Rad Laboratories, Inc. company research, Bio-Rad Laboratories, Inc. equity research, Bio-Rad Laboratories, Inc. stock analysis, Bio-Rad Laboratories, Inc. AI company analysis, Bio-Rad Laboratories, Inc. capital allocation, Bio-Rad Laboratories, Inc. risk analysis, Bio-Rad Laboratories, Inc. competitive position, Bio-Rad Laboratories, Inc. long-term growth.